review article | Q7318358 |
scholarly article | Q13442814 |
P356 | DOI | 10.1007/S00702-017-1744-5 |
P698 | PubMed publication ID | 28620834 |
P50 | author | Arun Singh | Q64821247 |
Goichi Beck | Q87975371 | ||
P2093 | author name string | Stella M Papa | |
P2860 | cites work | Levodopa therapy: consequences of the nonphysiologic replacement of dopamine | Q64891722 |
MK-801 reverses effects of chronic levodopa on D1 and D2 dopamine agonist-induced rotational behavior | Q70865163 | ||
Single cell studies of the primate putamen. I. Functional organization | Q71297006 | ||
Blockade of cannabinoid type 1 receptors augments the antiparkinsonian action of levodopa without affecting dyskinesias in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated rhesus monkeys | Q80609691 | ||
Functional organization of the basal ganglia: Therapeutic implications for Parkinson's disease | Q22252880 | ||
Regulation of parkinsonian motor behaviours by optogenetic control of basal ganglia circuitry | Q24630976 | ||
Regional, cellular, and subcellular variations in the distribution of D1 and D5 dopamine receptors in primate brain | Q28276882 | ||
Internal globus pallidus discharge is nearly suppressed during levodopa-induced dyskinesias | Q28376108 | ||
Receptor subtypes involved in the presynaptic and postsynaptic actions of dopamine on striatal interneurons | Q28589923 | ||
Subthalamic, not striatal, activity correlates with basal ganglia downstream activity in normal and parkinsonian monkeys | Q28829588 | ||
Up and down states in striatal medium spiny neurons simultaneously recorded with spontaneous activity in fast-spiking interneurons studied in cortex-striatum-substantia nigra organotypic cultures. | Q48558799 | ||
Two-state membrane potential transitions of striatal spiny neurons as evidenced by numerical simulations and electrophysiological recordings in awake monkeys. | Q48589246 | ||
Prolonged and extrasynaptic excitatory action of dopamine mediated by D1 receptors in the rat striatum in vivo | Q48654037 | ||
Differential effects of levodopa on dopaminergic function in early and advanced Parkinson's disease | Q48789225 | ||
Coordinated expression of dopamine receptors in neostriatal medium spiny neurons | Q48890601 | ||
The origins of two-state spontaneous membrane potential fluctuations of neostriatal spiny neurons. | Q49048418 | ||
D2 dopamine receptors reduce N-type Ca2+ currents in rat neostriatal cholinergic interneurons through a membrane-delimited, protein-kinase-C-insensitive pathway. | Q52524413 | ||
D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons | Q29615480 | ||
The functional anatomy of basal ganglia disorders | Q29617461 | ||
Primate models of movement disorders of basal ganglia origin | Q29618489 | ||
D1 and D2 dopamine-receptor modulation of striatal glutamatergic signaling in striatal medium spiny neurons | Q29619181 | ||
Dichotomous dopaminergic control of striatal synaptic plasticity | Q30493521 | ||
Transient stimulation of distinct subpopulations of striatal neurons mimics changes in action value | Q30573943 | ||
Concurrent activation of striatal direct and indirect pathways during action initiation. | Q30579307 | ||
Spatiotemporal pattern of striatal ERK1/2 phosphorylation in a rat model of L-DOPA-induced dyskinesia and the role of dopamine D1 receptors. | Q30594829 | ||
Cell type-specific plasticity of striatal projection neurons in parkinsonism and L-DOPA-induced dyskinesia | Q30650489 | ||
Abnormalities in metabolic network activity precede the onset of motor symptoms in Parkinson's disease | Q33835425 | ||
Synaptic transmission in the striatum: from plasticity to neurodegeneration | Q33869405 | ||
Single-axon tracing study of neurons of the external segment of the globus pallidus in primate | Q33888949 | ||
Dopaminergic modulation of neuronal excitability in the striatum and nucleus accumbens | Q33904968 | ||
Single cell studies of the primate putamen. II. Relations to direction of movement and pattern of muscular activity | Q34266944 | ||
Efferent projections of the subthalamic nucleus in the squirrel monkey as studied by the PHA-L anterograde tracing method | Q34323041 | ||
Functional and pathophysiological models of the basal ganglia | Q34413699 | ||
Striatal spine plasticity in Parkinson's disease | Q34416203 | ||
Dopaminergic control of corticostriatal long-term synaptic depression in medium spiny neurons is mediated by cholinergic interneurons. | Q34521936 | ||
Circuits and circuit disorders of the basal ganglia | Q34599488 | ||
Dopamine D2 receptor overexpression alters behavior and physiology in Drd2-EGFP mice | Q34780457 | ||
Role of Striatum in the Pause and Burst Generation in the Globus Pallidus of 6-OHDA-Treated Rats | Q35039660 | ||
Presynaptic effects of levodopa and their possible role in dyskinesia | Q35040280 | ||
Goal-directed and habitual control in the basal ganglia: implications for Parkinson's disease | Q35072636 | ||
Dopamine regulates distinctively the activity patterns of striatal output neurons in advanced parkinsonian primates | Q35138420 | ||
Dendrite spines plasticity in brain disorders | Q35551073 | ||
The Basal Ganglia and involuntary movements: impaired inhibition of competing motor patterns | Q35564115 | ||
Anatomical funneling, sparse connectivity and redundancy reduction in the neural networks of the basal ganglia | Q35830621 | ||
GABAergic microcircuits in the neostriatum | Q35912996 | ||
Inversion of dopamine responses in striatal medium spiny neurons and involuntary movements | Q35932567 | ||
A comparison of striatal-dependent behaviors in wild-type and hemizygous Drd1a and Drd2 BAC transgenic mice | Q36168175 | ||
Bad oscillations in Parkinson's disease. | Q36611479 | ||
Pathological synchronization in Parkinson's disease: networks, models and treatments | Q36833065 | ||
Differential innervation of direct- and indirect-pathway striatal projection neurons. | Q37060461 | ||
The cannabinoid system in Parkinson's disease: multiple targets to motor effects | Q37146722 | ||
Human striatal recordings reveal abnormal discharge of projection neurons in Parkinson's disease. | Q37213655 | ||
Molecular mechanisms of L-DOPA-induced dyskinesia | Q37247578 | ||
Molecular mechanisms underlying levodopa-induced dyskinesia. | Q37264455 | ||
Control of basal ganglia output by direct and indirect pathway projection neurons. | Q37325384 | ||
Striatal plasticity and basal ganglia circuit function | Q37336143 | ||
Modeling Parkinson's disease in monkeys for translational studies, a critical analysis. | Q37656643 | ||
Levodopa-induced dyskinesias in patients with Parkinson's disease: filling the bench-to-bedside gap. | Q37794467 | ||
Modeling dyskinesia in animal models of Parkinson disease | Q38077617 | ||
Dopaminergic modulation of striatal networks in health and Parkinson's disease | Q38233462 | ||
Direct and indirect pathways of basal ganglia: a critical reappraisal | Q38234309 | ||
The generation of natural firing patterns in neostriatal neurons | Q40714693 | ||
Striatal interneurones: chemical, physiological and morphological characterization | Q40991491 | ||
Transcranial magnetic stimulation follow-up study in early Parkinson's disease: A decline in compensation with disease progression? | Q41261915 | ||
Therapeutic doses of L-dopa reverse hypersensitivity of corticostriatal D2-dopamine receptors and glutamatergic overactivity in experimental parkinsonism. | Q42461972 | ||
Selective innervation of neostriatal interneurons by a subclass of neuron in the globus pallidus of the rat. | Q42463448 | ||
Subthalamic nucleus lesion reverses motor abnormalities and striatal glutamatergic overactivity in experimental parkinsonism. | Q42478271 | ||
Effects of L-dopa on extracellular dopamine in striatum of normal and 6-hydroxydopamine-treated rats | Q42478464 | ||
Representation of action-specific reward values in the striatum. | Q42487049 | ||
Firing patterns and correlations of spontaneous discharge of pallidal neurons in the normal and the tremulous 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine vervet model of parkinsonism. | Q42495652 | ||
Electrophysiology of dopamine-denervated striatal neurons. Implications for Parkinson's disease | Q42497576 | ||
Endocannabinoid-mediated rescue of striatal LTD and motor deficits in Parkinson's disease models | Q42508054 | ||
Cortical slow oscillatory activity is reflected in the membrane potential and spike trains of striatal neurons in rats with chronic nigrostriatal lesions. | Q42508172 | ||
A neural correlate of response bias in monkey caudate nucleus. | Q42524148 | ||
Levodopa-induced dyskinesias improved by a glutamate antagonist in Parkinsonian monkeys | Q42556711 | ||
Reduction of L-DOPA-induced dyskinesia by the selective metabotropic glutamate receptor 5 antagonist 3-[(2-methyl-1,3-thiazol-4-yl)ethynyl]pyridine in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned macaque model of Parkinson's disease | Q43128784 | ||
Effect of the metabotropic glutamate receptor type 5 antagonists MPEP and MTEP in parkinsonian monkeys | Q43194412 | ||
Opposite influences of endogenous dopamine D1 and D2 receptor activation on activity states and electrophysiological properties of striatal neurons: studies combining in vivo intracellular recordings and reverse microdialysis. | Q43833757 | ||
D1 dopamine receptor supersensitivity in the dopamine-depleted striatum results from a switch in the regulation of ERK1/2/MAP kinase. | Q44037073 | ||
Activation of dopamine D1-like receptors excites LTS interneurons of the striatum | Q44051643 | ||
Experimental parkinsonism alters endocannabinoid degradation: implications for striatal glutamatergic transmission. | Q44102387 | ||
Striatal metabotropic glutamate receptor function following experimental parkinsonism and chronic levodopa treatment | Q44214927 | ||
Dual κ-agonist/μ-antagonist opioid receptor modulation reduces levodopa-induced dyskinesia and corrects dysregulated striatal changes in the nonhuman primate model of Parkinson disease. | Q44350349 | ||
Loss of bidirectional striatal synaptic plasticity in L-DOPA-induced dyskinesia | Q44383212 | ||
Behavioral modulation of sensory responses of primate putamen neurons | Q44739793 | ||
Nucleus accumbens D2R cells signal prior outcomes and control risky decision-making | Q46142853 | ||
Origin of the slow afterhyperpolarization and slow rhythmic bursting in striatal cholinergic interneurons. | Q46703331 | ||
Selective elimination of glutamatergic synapses on striatopallidal neurons in Parkinson disease models. | Q46896175 | ||
Slow oscillatory activity of rat globus pallidus neurons in vitro | Q46899509 | ||
Partial deficit of pantothenate kinase 2 catalytic activity in a case of tremor-predominant neurodegeneration with brain iron accumulation | Q46922079 | ||
Spontaneous activity of neostriatal cholinergic interneurons in vitro. | Q47904266 | ||
Dopamine-dependent long-term depression is expressed in striatal spiny neurons of both direct and indirect pathways: implications for Parkinson's disease. | Q48114419 | ||
Critical involvement of cAMP/DARPP-32 and extracellular signal-regulated protein kinase signaling in L-DOPA-induced dyskinesia | Q48124096 | ||
Role of high-affinity dopamine uptake and impulse activity in the appearance of extracellular dopamine in striatum after administration of exogenous L-DOPA: studies in intact and 6-hydroxydopamine-treated rats | Q48251249 | ||
Rebalance of striatal NMDA/AMPA receptor ratio underlies the reduced emergence of dyskinesia during D2-like dopamine agonist treatment in experimental Parkinson's disease | Q48261352 | ||
The role of primate putamen neurons in the association of sensory stimuli with movement | Q48324341 | ||
Cholinergic and dopaminergic modulation of potassium conductances in neostriatal neurons. | Q48370456 | ||
Chronic high-frequency stimulation of the subthalamic nucleus and L-DOPA treatment in experimental parkinsonism: effects on motor behaviour and striatal glutamate transmission | Q48412047 | ||
Plasticity of synapses in the rat neostriatum after unilateral lesion of the nigrostriatal dopaminergic pathway. | Q48454428 | ||
Microstimulation of the primate neostriatum. II. Somatotopic organization of striatal microexcitable zones and their relation to neuronal response properties | Q48482144 | ||
P433 | issue | 3 | |
P921 | main subject | striatum | Q1319792 |
P304 | page(s) | 449-460 | |
P577 | publication date | 2017-06-15 | |
P1433 | published in | Journal of Neural Transmission | Q15750921 |
P1476 | title | Dysregulation of striatal projection neurons in Parkinson's disease | |
P478 | volume | 125 |
Q64968192 | A Selective Phosphodiesterase 10A Inhibitor Reduces L-Dopa-Induced Dyskinesias in Parkinsonian Monkeys |
Q92603845 | Dopaminergic pathway and primary visual cortex are involved in the freezing of gait in Parkinson's disease: a PET-CT study |
Q49246060 | Glutamatergic Tuning of Hyperactive Striatal Projection Neurons Controls the Motor Response to Dopamine Replacement in Parkinsonian Primates |
Q64759312 | Neuropathology and pathogenesis of extrapyramidal movement disorders: a critical update-I. Hypokinetic-rigid movement disorders |
Q50103497 | Non-human primate research of basal ganglia and movement disorders: advances and challenges |
Q92913091 | Role of striatal ΔFosB in l-Dopa-induced dyskinesias of parkinsonian nonhuman primates |
Q90695353 | The globus pallidus orchestrates abnormal network dynamics in a model of Parkinsonism |
Search more.